Delivery Order SPE2DB24D3013-SPE2DB25FFGCF

Award Date 10/31/24
Potential Completion Date 11/1/24
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has a firm fixed price of $6,552.70 and an ultimate completion date of April 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.30, is for the delivery of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL medication. The contract is a Firm Fixed Price Delivery Order with a completion date of May 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract, valued at $2,257.28, was awarded by the Defense Logistics Agency (DLA) as a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of January 30, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $40,009.96, is for the delivery of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml to DLA. The contract is a Firm Fixed Price Delivery Order with a completion date of July 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract, valued at $128,715.25, is a delivery order placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 27, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The $5,943.62 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, under contract SPE2DB20D3103/SPE2DB24FP4M6. The contract has a ceiling value of $5,943.62 and an ultimate completion date of July 9, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml medication. The contract has a ceiling value of $14,401.61 and is a firm fixed-price delivery order with an ultimate completion date of April 1, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The contract, valued at $4,906.55, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of January 28, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract, valued at $10,927.90, was awarded by the Defense Logistics Agency (DLA) and has a completion date of December 11, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,796.65, is a Firm Fixed Price Delivery Order for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The contract has a period of performance through July 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFGCF
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml medication. The award, valued at $26,440.20, was made by the Defense Logistics Agency (DLA), a defense agency, under a Delivery Order contract type with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of November 1, 2024. This award is not designated as a set-aside contract. The contract represents a delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/20/25, 2:16 PM